معرفی
Bruce A. Leicher is an Affiliate Professor of Law at the University of New Hampshire Law School, where he teaches biotechnology law. He is also in private practice, advising executives and chief legal officers, leveraging over 40 years of legal experience in the life sciences sector.
His professional background includes serving as General Counsel and in senior legal roles at prominent biotechnology companies such as Momenta Pharmaceuticals, Millennium Pharmaceuticals, and Genetics Institute. He has also been involved with emerging biotech firms and major law firms, including Hill and Barlow (where he co-chaired the Life Sciences Practice Group), Hale and Dorr, and Butler & Binion.
- Former Chair, Biosimilars Council, Association for Accessible Medicines
- Law Clerk to the Honorable Thomas F. Hogan, U.S. District Court for the District of Columbia
Dr. Leicher earned his J.D. from Georgetown University Law Center and a B.A. from the University of Rochester. His expertise lies at the intersection of law and biotechnology, particularly in regulatory, intellectual property, and compliance issues affecting the life sciences industry.
While no recent publications are listed, his teaching and practice focus suggest sustained engagement with legal developments in biotechnology and biosimilars. He has no listed scientific awards.
He mentors legal professionals and industry leaders through teaching and advisory roles, though no formal advisees are mentioned. There is no indication of grant funding or laboratory affiliations, consistent with a legal rather than scientific research career.
